Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Involvement of Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus

NCT05424627 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT05424627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05424627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Involvement of Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Not yet recruiting
Start date
July 15, 2022
Completion date
January 15, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus